The pathology of NMOSD is distinguished from other demyelinating diseases, such as multiple sclerosis, by the presence of the aquaporin-4 (AQP4) serological antibody and by humorally mediated inflammatory markers associated with AQP4-depleted lesions, including perivascular immunoglobulin and complement [2, 3]. Here, AQP4 is linked to multiple sclerosis.